AI Stock Finder
Smart Investing, Simplified
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout

Adma Biologics, Inc. ADMA Stock Forecast

AI-powered price prediction and analysis for Adma Biologics, Inc. ยท Updated Aug 18, 2026

AI 90-Day Forecast
HOLD
7 Days
โ–ˆโ–ˆ%
30 Days
โ–ˆโ–ˆ%
90 Days
โ–ˆโ–ˆ%
AI Confidence: 17% Spearman Correlation
August 18, 2026

See ADMA's Exact Price Target

Create a free account and follow this stock to unlock its full AI forecast โ€” 3 stocks free.

Sign Up Free with Google
โœ“ Free account ยท โœ“ 30-day trial ยท โœ“ Cancel anytime

Price Chart

Loading chart...

Key Statistics

Market Cap
$2.15B
P/E Ratio
12.7x
P/B Ratio
5.27x
ROE
-0.1%
Revenue
$512M
Current Ratio
6.97x
D/E Ratio
0.68x

About Adma Biologics, Inc.

Adma Biologics, Inc. (ADMA) operates in the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. .

Life Sciences Biological Products, (No Diagnostic Substances) Nasdaq Mid Cap

Latest News

  • Loading...

Where ADMA sits on the market map

Explore the map →

Biological Products, (No Diagnostic Substances) Peers

Company Ticker AI Signal Market Cap P/E
Acumen Pharmaceuticals, Inc. ABOS โ–ˆโ–ˆ% $198M -x
Abpro Holdings, Inc. ABPO โ–ˆโ–ˆ% $1M -x
Alpha Cognition Inc. ACOG โ–ˆโ–ˆ% $187M -x
Adaptimmune Therapeutics Plc ADAPY โ–ˆโ–ˆ% $8M -x
Adma Biologics, Inc. ADMA โ–ˆโ–ˆ% $2.15B 12.7x
Adaptive Biotechnologies Corp ADPT โ–ˆโ–ˆ% $3.91B -x
Agenus Inc AGEN โ–ˆโ–ˆ% $305M 3.3x
Agentix Corp. AGTX โ–ˆโ–ˆ% $800K -x
Aim Immunotech Inc. AIM โ–ˆโ–ˆ% $6M -x
Alector, Inc. ALEC โ–ˆโ–ˆ% $247M -x
Aligos Therapeutics, Inc. ALGS โ–ˆโ–ˆ% $42M -x
Allogene Therapeutics, Inc. ALLO โ–ˆโ–ˆ% $718M -x
Alvotech ALVO โ–ˆโ–ˆ% $1.23B -x
Amgen Inc AMGN โ–ˆโ–ˆ% $226.72B 25.9x
Apogee Therapeutics, Inc. APGE โ–ˆโ–ˆ% $10.14B -x
Adaptin Bio, Inc. APTN โ–ˆโ–ˆ% $57M -x
Aptose Biosciences Inc. APTOF โ–ˆโ–ˆ% $4M -x
Argenx Se ARGX โ–ˆโ–ˆ% $61.45B -x
Armata Pharmaceuticals, Inc. ARMP โ–ˆโ–ˆ% $166M -x
Artiva Biotherapeutics, Inc. ARTV โ–ˆโ–ˆ% $571M -x
Atara Biotherapeutics, Inc. ATRA โ–ˆโ–ˆ% $79M -x
Atyr Pharma Inc ATYR โ–ˆโ–ˆ% $51M -x
Aura Biosciences, Inc. AURA โ–ˆโ–ˆ% $844M -x
Autolus Therapeutics Plc AUTL โ–ˆโ–ˆ% $607M -x
Anavex Life Sciences โ€ฆ AVXL โ–ˆโ–ˆ% $297M -x
Bioatla, Inc. BCAB โ–ˆโ–ˆ% $5M -x
Biocardia, Inc. BCDA โ–ˆโ–ˆ% $14M -x
Brainstorm Cell Therapeutics โ€ฆ BCLI โ–ˆโ–ˆ% $16M -x
Biocryst Pharmaceuticals Inc BCRX โ–ˆโ–ˆ% $2.45B -x
Black Diamond Therapeutics, โ€ฆ BDTX โ–ˆโ–ˆ% $118M -x
Beam Therapeutics Inc. BEAM โ–ˆโ–ˆ% $2.80B -x
Biogen Inc. BIIB โ–ˆโ–ˆ% $30.79B 22.4x
Black Hawk Acquisition โ€ฆ BKHA โ–ˆโ–ˆ% $49M 96.2x
Biontech Se BNTX โ–ˆโ–ˆ% $23.01B -x
Cabaletta Bio, Inc. CABA โ–ˆโ–ˆ% $490M -x
Candel Therapeutics, Inc. CADL โ–ˆโ–ˆ% $926M -x
C4 Therapeutics, Inc. CCCC โ–ˆโ–ˆ% $524M -x
Creative Medical Technology โ€ฆ CELZ โ–ˆโ–ˆ% $7M -x
Cero Therapeutics Holdings, โ€ฆ CERO โ–ˆโ–ˆ% $480K -x
Cullinan Therapeutics, Inc. CGEM โ–ˆโ–ˆ% $1.31B -x
Compugen Ltd CGEN โ–ˆโ–ˆ% $222M 3.1x
Cg Oncology, Inc. CGON โ–ˆโ–ˆ% $6.81B -x
Cognition Therapeutics Inc CGTX โ–ˆโ–ˆ% $94M -x
Coherus Oncology, Inc. CHRS โ–ˆโ–ˆ% $178M -x
Calidi Biotherapeutics, Inc. CLDI โ–ˆโ–ˆ% $3M -x
Cellectis S.A. CLLS โ–ˆโ–ˆ% $313M -x
Compass Therapeutics, Inc. CMPX โ–ˆโ–ˆ% $416M -x
Mosaic Immunoengineering Inc. CPMV โ–ˆโ–ˆ% $440K -x
Cardiff Oncology, Inc. CRDF โ–ˆโ–ˆ% $71M -x
Cardiol Therapeutics Inc. CRDL โ–ˆโ–ˆ% $216M -x
Curis Inc CRIS โ–ˆโ–ˆ% $4M -x
Crispr Therapeutics Ag CRSP โ–ˆโ–ˆ% $5.25B -x
Champions Oncology, Inc. CSBR โ–ˆโ–ˆ% $70M -x
Cel Sci Corp CVM โ–ˆโ–ˆ% $27M -x
Dbv Technologies S.A. DBVT โ–ˆโ–ˆ% $908M -x
Ginkgo Bioworks Holdings, โ€ฆ DNA โ–ˆโ–ˆ% $441M -x
Denali Therapeutics Inc. DNLI โ–ˆโ–ˆ% $3.89B -x
Precision Biosciences Inc DTIL โ–ˆโ–ˆ% $209M -x
Dyadic International Inc DYAI โ–ˆโ–ˆ% $28M -x
Editas Medicine, Inc. EDIT โ–ˆโ–ˆ% $436M -x
Eikon Therapeutics, Inc. EIKN โ–ˆโ–ˆ% $567M -x
Elutia Inc. ELUT โ–ˆโ–ˆ% $43M 0.8x
Engene Therapeutics Inc. ENGN โ–ˆโ–ˆ% $114M -x
Entera Bio Ltd. ENTX โ–ˆโ–ˆ% $143M -x
Viskase Holdings, Inc. ENZN โ–ˆโ–ˆ% $67M -x
Estrella Immunopharma, Inc. ESLA โ–ˆโ–ˆ% $33M -x
Evaxion A/S EVAX โ–ˆโ–ˆ% $26M -x
Exelixis, Inc. EXEL โ–ˆโ–ˆ% $13.02B 15.1x
Exozymes Inc. EXOZ โ–ˆโ–ˆ% $58M -x
Fate Therapeutics Inc FATE โ–ˆโ–ˆ% $306M -x
4d Molecular Therapeutics, โ€ฆ FDMT โ–ˆโ–ˆ% $803M -x
Fennec Pharmaceuticals Inc. FENC โ–ˆโ–ˆ% $414M -x
Gilead Sciences, Inc. GILD โ–ˆโ–ˆ% $171.70B -x
Monte Rosa Therapeutics, โ€ฆ GLUE โ–ˆโ–ˆ% $1.32B -x
Genenta Science S.P.A. GNTA โ–ˆโ–ˆ% $63M -x
Green Planet Bio โ€ฆ GPLB โ–ˆโ–ˆ% $180K -x
Greenland Mines Ltd GRML โ–ˆโ–ˆ% $31M -x
Halozyme Therapeutics, Inc. HALO โ–ˆโ–ˆ% $11.25B 27.2x
Humacyte, Inc. HUMA โ–ˆโ–ˆ% $168M -x
Immunitybio, Inc. IBRX โ–ˆโ–ˆ% $7.97B -x
Inhibikase Therapeutics, Inc. IKT โ–ˆโ–ˆ% $318M -x
Imagenebio, Inc. IMA โ–ˆโ–ˆ% $66M -x
Immunocore Holdings Plc IMCR โ–ˆโ–ˆ% $1.76B -x
Immatics N.V. IMTX โ–ˆโ–ˆ% $1.27B -x
Immunovant, Inc. IMVT โ–ˆโ–ˆ% $8.63B -x
In8bio, Inc. INAB โ–ˆโ–ˆ% $11M -x
Mink Therapeutics, Inc. INKT โ–ˆโ–ˆ% $60M -x
Inmune Bio, Inc. INMB โ–ˆโ–ˆ% $60M -x
Intensity Therapeutics, Inc. INTS โ–ˆโ–ˆ% $13M -x
Iovance Biotherapeutics, Inc. IOVA โ–ˆโ–ˆ% $3.16B -x
Century Therapeutics, Inc. IPSC โ–ˆโ–ˆ% $349M -x
Invivyd, Inc. IVVD โ–ˆโ–ˆ% $213M -x
Zura Bio Ltd JATT โ–ˆโ–ˆ% $100M -x
Jasper Therapeutics, Inc. JSPR โ–ˆโ–ˆ% $26M -x
Kalaris Therapeutics, Inc. KLRS โ–ˆโ–ˆ% $97M -x
Kodiak Sciences Inc. KOD โ–ˆโ–ˆ% $2.60B -x
Krystal Biotech, Inc. KRYS โ–ˆโ–ˆ% $9.83B 40.7x
Kymera Therapeutics, Inc. KYMR โ–ˆโ–ˆ% $9.72B -x
Kyverna Therapeutics, Inc. KYTX โ–ˆโ–ˆ% $503M -x
Lineage Cell Therapeutics, โ€ฆ LCTX โ–ˆโ–ˆ% $271M -x
Lenz Therapeutics, Inc. LENZ โ–ˆโ–ˆ% $152M -x
Atyr Pharma Inc LIFE โ–ˆโ–ˆ% $3.38B -x
Liminatus Pharma, Inc. LIMN โ–ˆโ–ˆ% $9M -x
Leonabio, Inc. LONA โ–ˆโ–ˆ% $75M -x
Lexeo Therapeutics, Inc. LXEO โ–ˆโ–ˆ% $381M -x
Maze Therapeutics, Inc. MAZE โ–ˆโ–ˆ% $1.61B -x
Mesoblast Ltd MESO โ–ˆโ–ˆ% $2.02B -x
Meiragtx Holdings Plc MGTX โ–ˆโ–ˆ% $1.27B 16.1x
Metagenomi Therapeutics, Inc. MGX โ–ˆโ–ˆ% $46M -x
Molecular Partners Ag MOLN โ–ˆโ–ˆ% $173M -x
Moderna, Inc. MRNA โ–ˆโ–ˆ% $25.26B -x
Neurocrine Biosciences Inc NBIX โ–ˆโ–ˆ% $15.52B 22.0x
Neumora Therapeutics, Inc. NMRA โ–ˆโ–ˆ% $296M -x
Novavax Inc NVAX โ–ˆโ–ˆ% $1.33B -x
Ocugen, Inc. OCGN โ–ˆโ–ˆ% $458M -x
Outlook Therapeutics, Inc. OTLK โ–ˆโ–ˆ% $183M -x
Palisade Bio, Inc. PALI โ–ˆโ–ˆ% $371M -x
Passage Bio, Inc. PASG โ–ˆโ–ˆ% $15M -x
Vaxcyte, Inc. PCVX โ–ˆโ–ˆ% $8.41B -x
Biomx Inc. PHGE โ–ˆโ–ˆ% $2M -x
Pluri Inc. PLUR โ–ˆโ–ˆ% $17M -x
Protalix Biotherapeutics, Inc. PLX โ–ˆโ–ˆ% $178M 9.4x
Pharmacyte Biotech, Inc. PMCB โ–ˆโ–ˆ% $6M -x
Prime Medicine, Inc. PRME โ–ˆโ–ˆ% $558M -x
Prokidney Corp. PROK โ–ˆโ–ˆ% $531M -x
Pelthos Therapeutics Inc. PTHS โ–ˆโ–ˆ% $102M -x
Qiagen N.V. QGEN โ–ˆโ–ˆ% $9.32B -x
Quince Therapeutics, Inc. QNCX โ–ˆโ–ˆ% $35M -x
Replimune Group, Inc. REPL โ–ˆโ–ˆ% $1.26B -x
Repligen Corp RGEN โ–ˆโ–ˆ% $9.41B 226.6x
Regenxbio Inc. RGNX โ–ˆโ–ˆ% $711M -x
Relay Therapeutics, Inc. RLAY โ–ˆโ–ˆ% $4.34B -x
Revolution Medicines, Inc. RVMD โ–ˆโ–ˆ% $43.64B -x
Recursion Pharmaceuticals, Inc. RXRX โ–ˆโ–ˆ% $1.69B -x
Sab Biotherapeutics, Inc. SABS โ–ˆโ–ˆ% $309M -x
Sana Biotechnology, Inc. SANA โ–ˆโ–ˆ% $1.06B -x
Scilex Holding Co SCLX โ–ˆโ–ˆ% $48M -x
Scinai Immunotherapeutics Ltd. SCNI โ–ˆโ–ˆ% $1M -x
Sangamo Therapeutics, Inc SGMO โ–ˆโ–ˆ% $29M -x
Sangamo Therapeutics, Inc SGMOQ โ–ˆโ–ˆ% $70M -x
Solid Biosciences Inc. SLDB โ–ˆโ–ˆ% $941M -x
Silexion Therapeutics Corp SLXN โ–ˆโ–ˆ% $570K -x
Senti Biosciences Holdings, โ€ฆ SNTI โ–ˆโ–ˆ% $14M -x
Scholar Rock Holding โ€ฆ SRRK โ–ˆโ–ˆ% $6.39B -x
Surrozen, Inc./De SRZN โ–ˆโ–ˆ% $282M -x
Sutro Biopharma, Inc. STRO โ–ˆโ–ˆ% $373M -x
Protara Therapeutics, Inc. TARA โ–ˆโ–ˆ% $232M -x
Tarsus Pharmaceuticals, Inc. TARS โ–ˆโ–ˆ% $3.07B -x
Tscan Therapeutics, Inc. TCRX โ–ˆโ–ˆ% $52M -x
Bio-Techne Corp TECH โ–ˆโ–ˆ% $11.34B 103.5x
Tectonic Therapeutic, Inc. TECX โ–ˆโ–ˆ% $689M -x
Instil Bio, Inc. TIL โ–ˆโ–ˆ% $50M -x
Tenaya Therapeutics, Inc. TNYA โ–ˆโ–ˆ% $154M -x
Taysha Gene Therapies, โ€ฆ TSHA โ–ˆโ–ˆ% $2.03B -x
Tevogen Inc. TVGN โ–ˆโ–ˆ% $29M -x
Twist Bioscience Corp TWST โ–ˆโ–ˆ% $7.45B -x
Voyager Acquisition Corp./Cayman โ€ฆ VACH โ–ˆโ–ˆ% $541M 80.4x
Valneva Se VALN โ–ˆโ–ˆ% $651M -x
Vericel Corp VCEL โ–ˆโ–ˆ% $2.27B 93.6x
Vir Biotechnology, Inc. VIR โ–ˆโ–ˆ% $1.59B -x
Vivosim Labs, Inc. VIVS โ–ˆโ–ˆ% $4M -x
Vor Biopharma Inc. VOR โ–ˆโ–ˆ% $1.25B 2.0x
Vaxart, Inc. VXRT โ–ˆโ–ˆ% $121M 3.2x
Voyager Therapeutics, Inc. VYGR โ–ˆโ–ˆ% $199M -x
Windtree Therapeutics Inc โ€ฆ WINT โ–ˆโ–ˆ% $40K -x
X4 Pharmaceuticals, Inc XFOR โ–ˆโ–ˆ% $406M -x
Zeo Scientifix, Inc. ZEOX โ–ˆโ–ˆ% $11M -x
Zivo Bioscience, Inc. ZIVO โ–ˆโ–ˆ% $16M -x
Zura Bio Ltd ZURA โ–ˆโ–ˆ% $555M -x

FAQ

  • Is Adma Biologics, Inc. a good stock to buy?

    Our AI analyzes Adma Biologics, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.

  • How accurate are Adma Biologics, Inc. predictions?

    Our AI achieves a 17% Spearman correlation for this stock, with 67%+ average accuracy across 4,000+ stocks analyzed daily.

  • How often are forecasts updated?

    Adma Biologics, Inc. forecasts are updated daily using the latest market data and AI models.

Ready to invest smarter?

Join thousands of investors using AI-powered stock predictions

Sign Up Free
โœ“ Free account ยท โœ“ 4,000+ stocks ยท โœ“ Daily updates

Looking for a deeper analysis of Adma Biologics, Inc.?

View full institutional-grade analysis on Intratio โ†’

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.

My Portfolio

Investment Dashboard

Loading your portfolio...